Holista Colltech Limited (ASX:HCT)

Market Cap	16.18M -54.0%
Revenue (ttm)	5.89M +0.8%
Net Income	-3.22M
EPS	-0.01
Shares Out	367.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	0.0440
Previous Close	0.0430
Day's Range	0.0440 - 0.0440
52-Week Range	0.0430 - 0.1050
Beta	1.28
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 1, 2026

About Holista Colltech

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it offers GI LiTE, a premix glycemic ...

• Industry: Packaged Foods
• Sector: Consumer Staples
• CEO: Leong Loong
• Employees: 58
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HCT

Financial Performance

In 2025, Holista Colltech's revenue was 5.79 million, an increase of 3.08% compared to the previous year's 5.61 million. Losses were -948,921, 1026.8% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 15, 2026

Data Sources Report a data error